While switching, youll want to track the progress towards achieving significant weight loss: body weight and waist circumference (to monitor fat loss and body composition) blood sugar / HbA1c / fasting insulin (for glycemic control) blood pressure and heart rate (some of these medications can raise heart-rate) side-effects: GI symptoms (nausea, vomiting), possible more intense responses with retatrutide your diet, hydration status, and workout/energy levels (as your body adjusts to the new medicine) Regular check-ins (every 4 weeks initially) help your provider catch anything needing adjustment
Electrolyte shifts, especially low sodium or potassium after repeated vomiting or diarrhea, can also cause lightheadedness and should not be overlooked when a patient reports persistent symptoms
GLP-1 is what is known as a glucagon-like peptide-1 (GLP-1) receptor agonist, acting in much the same way as GLP-1, a hormone that is released from the intestine following a meal
These trials evaluated the efficacy of semaglutide (Ozempic) in lowering HbA1c levels, a key marker for blood sugar control in patients with type 2 diabetes
Some patients may switch from tirzepatide to semaglutide because of tolerance, side effects, cost, availability or provider recommendation